Kairos Pharma (KAPA) Interest & Investment Income (2025)
Kairos Pharma's (KAPA) quarterly Interest & Investment Income came in at $34000.0 in Q2 2025, up 750.0% on a QoQ basis from $4000.0 in Q1 2025.
Kairos Pharma (KAPA) Interest & Investment Income (2025) Analysis & Trends
Kairos Pharma (KAPA) has 1 years of Interest & Investment Income data on file, last reported at $34000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 28.14 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 10.98 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 5.13 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 115.94 Mn |
| 10 | Kairos Pharma | 5.50 Mn | 168,380.07 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 34,000.00 |
| Mar 31, 2025 | 4,000.00 |